Aktie A041960 KOMIPHARM INTERNATIONAL CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Komipharm International Co., Ltd.

Aktien

A041960

KR7041960006

A041960

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 03.05.2024 		% 5 Tage % 1. Jan.
4’220 KRW +1.44% Intraday Chart für Komipharm International Co., Ltd. +1.08% +0.72%
20.03. Komipharm International Co., Ltd. (KOSDAQ:A041960) gibt einen Aktienrückkauf für 241.545 Aktien bekannt. CI
20.03. Komipharm International Co., Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Komipharm International Co., Ltd. announces an Equity Buyback for 241,545 shares.
Komipharm International Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Komipharm International Co., Ltd. authorizes a Buyback Plan.
Komipharm International Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Komipharm International Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Komipharm International Co., Ltd. announced that it has received KRW 15 billion in funding from a group of investors
Komipharm International Co., Ltd. announced that it expects to receive KRW 15 billion in funding
Komipharm International Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Komipharm International Co., Ltd.'s Equity Buyback announced on September 23, 2022, has expired.
Tranche Update on Komipharm International Co., Ltd.'s Equity Buyback Plan announced on September 23, 2022.
Komipharm International Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Komipharm International Co., Ltd. announces an Equity Buyback for 146,842 shares.
Komipharm International Co., Ltd. authorizes a Buyback Plan.
Komipharm International Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Komipharm International Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Komipharm International Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Komipharm International Australia Pty. Ltd. announced that it has received AUD 3.58605 million in funding from Komipharm International Co., Ltd.
Komipharm International Australia Pty. Ltd. announced that it expects to receive AUD 3.58605 million in funding from Komipharm International Co., Ltd.
Komipharm International Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Komipharm International Co., Ltd. announced that it has received KRW 10 billion in funding
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A041960 Aktie
  4. Nachrichten Komipharm International Co., Ltd.
  5. Andere Sprachen